PAR2 promotes malignancy in lung adenocarcinoma.
Wang B, Wu MD, Lan YJ, Jia CY, Zhao H, Yang KP, Liu HN, Sun SZ, Tao RC, Lu XD, Zhang ZF.
Wang B, et al. Among authors: yang kp.
Am J Transl Res. 2024 Dec 15;16(12):7416-7426. doi: 10.62347/STSI5751. eCollection 2024.
Am J Transl Res. 2024.
PMID: 39822538
Free PMC article.